Table of Contents
What changed
Revenue fell 12.9% to NZ$1,533.6m (HY25: NZ$1,761.2m), yet earnings moved sharply in the opposite direction. Normalised EBITDAF reached NZ$307m, up 38% on HY25's NZ$222m, and reported EBITDAF came in at NZ$303m (+40%). PBT lifted 44.3% to NZ$135.2m, while NPAT grew 35.3% to NZ$95.1m — a 9.0 percentage-point gap explained almost entirely by a higher effective tax rate (29.7% vs 25.0% in HY25), with no discontinued operations disclosed.
Operating cash flow more than doubled to NZ$264.0m from NZ$126.3m, a strong headline. However, the company's own disclosed Operating Free Cash Flow was negative at NZ$183m, reflecting capex of NZ$111.6m (up from NZ$58.1m) and a material working-capital build. Inventories surged NZ$140.7m to NZ$317.9m (+79.4%), lifting total operating working capital to NZ$565.7m from NZ$405.0m. Gross borrowings declined modestly, and net debt improved to approximately NZ$1,393.7m from NZ$1,426.7m. The interim dividend was lifted 2.4% to 7.3 cents per share.
What matters
-
The revenue/earnings divergence is the central story. A 12.9% revenue decline alongside a 38% EBITDAF increase implies a substantial compression in energy procurement or operating costs. Genesis flagged active management of its gas position into Q3 FY26 and broad fuel diversity across gas, coal, and renewables, but the precise cost drivers behind this margin expansion are not itemised in the available extract. Understanding whether this margin widening reflects durable structural positioning or favourable spot conditions in the half is the key analytical question.
-
The inventory build demands scrutiny. Inventories rose NZ$140.7m to NZ$317.9m in a single half, pushing inventory days from 18.3 to 37.7. For an integrated energy company this likely reflects gas or coal stock-building ahead of winter — the release notes Genesis is managing its gas position into Q3 FY26. If that stock was purchased at below-market rates it could be a value-creating move; if it reflects precautionary over-procurement it represents a working-capital drag that will need unwinding. Either way, it inflates the OCF-to-EBITDAF conversion ratio while the inventory sits unsold.
-
The normalised versus reported EBITDAF gap (NZ$4m) is unexplained in the supplied extract. The NZ$307m normalised and NZ$303m reported figures are both disclosed, but the reconciling items are not provided. This limits independent quality assessment of whether the normalisation adjustments are benign or substantive.
Expectations
No quantitative FY26 guidance was disclosed. Genesis's qualitative commentary centres on continued Gen35 strategy execution and gas-position management into Q3 FY26.
The historical seasonality pattern is instructive: in FY25, the first half contributed only 41.6% of full-year NPAT and 48.1% of full-year revenue, with H2 typically stronger as winter demand lifts. HY26 NPAT of NZ$95.1m already exceeds HY25's NZ$70.3m by 35.3%, but the implied second-half NPAT required to match FY25's NZ$169.1m full-year result is only NZ$74.0m — a materially lower bar than HY25's actual H2 outturn of NZ$98.8m. On that basis, this half-year result, if the margin environment holds, puts Genesis on a trajectory comfortably above FY25's full-year outcome.
Annualised HY26 revenue of approximately NZ$3,067m sits below FY25's NZ$3,662m, reinforcing that the earnings improvement is margin-driven rather than volume-driven. Whether the gas position build translates into volume and margin in H2 is the key variable.
Quality of result
The earnings quality picture is mixed. Margin expansion on lower revenue is a genuinely positive operating signal, consistent with better fuel-cost management or improved wholesale position outcomes. The 44.3% PBT growth is the cleanest operating read, as it avoids the tax-rate distortion that compresses NPAT growth to 35.3%.
Cash conversion, however, warrants caution. The OCF-to-EBITDAF ratio improved to approximately 86% from 56.9%, which looks strong in isolation, but this is materially assisted by the NZ$140.7m inventory build sitting in working capital rather than being expensed. The company's own Operating Free Cash Flow figure of negative NZ$183m — after capex of NZ$111.6m and the working-capital build — is the more complete picture of cash generation available to service dividends and debt. The interim dividend of 7.3 cents represents a payout ratio of approximately 84.5% of NPAT, but is not covered by free cash flow in this half. This is not unusual for a capital-intensive utility mid-investment cycle, but it does mean the dividend is effectively being funded by balance-sheet capacity rather than free cash.
Leverage improved on an EBITDAF basis to approximately 4.5x from 6.4x, driven largely by EBITDAF expansion, which is the right direction but still elevated.
Unresolved
- What are the specific drivers of the NZ$85m EBITDAF uplift on lower revenue — is the margin improvement attributable to lower gas costs, better hydrology outcomes, improved retail margins, or wholesale position gains, and how much is repeatable into H2?
- The NZ$4m gap between normalised and reported EBITDAF is not reconciled in the supplied materials; the nature and scale of normalisation adjustments is not assessable.
- The NZ$140.7m inventory build is unexplained beyond a general reference to gas-position management. Whether this inventory was acquired at advantageous prices and how quickly it will be monetised in H2 is material to the earnings and cash flow outlook.
- Capex has nearly doubled half-on-half to NZ$111.6m. The composition between maintenance and Gen35 growth investment, and the expected full-year capex envelope, are not disclosed in the available extract.
- The effective tax rate jumped to 29.7% from 25.0%; the reasons for this step-up have not been addressed.
This briefing cannot assess the fair-value implications of the result because no share count, market price, or net debt per share data were supplied.
Key metrics
| Metric | HY26 | HY25 | Change |
|---|---|---|---|
| Revenue | $1.5m | $1.8m | -12.9% ↓ |
| Net profit after tax | $95.1m | $70.3m | +35.3% ↑ |
| Net cash inflow from operating activities | $264m | $126.3m | +109.0% ↑ |
| Interim dividend per share | 7.3c | 7.1c | +2.4% ↑ |
| Operating profit | $170.9m | $133.3m | +28.2% ↑ |
| Profit before tax | $135.2m | $93.7m | +44.3% ↑ |
| Total assets | $6.3m | $6.0m | +4.4% ↑ |
Source: annolyse.ai/briefings/gne-hy26
Analytical metrics
| Metric | HY26 | HY25 | Context |
|---|---|---|---|
| PBT growth | +44.3% | — | cleaner earnings measure |
| Effective tax rate | 29.7% | 25.0% | — |
| OCF / EBITDA (cash conversion) | 86.0% | 56.9% | stable |
| FCF pre-lease | −$183.0m | — | — |
| FCF / NPAT | -192.4% | — | complementary conversion metric |
| Capex % revenue | 7.3% | 3.3% | — |
| Capex | −$111.6m | $58.1m | −$169.7m |
| Free cash flow | −$183.0m | — | — |
| Debtor days | 29.4 | 23.5 | +5.9 days |
| Inventory days | 37.7 | 18.3 | +19.4 days |
| Operating working capital | $565.7m | $405.0m | +$160.7m absorbed |
| Trade debtors | $247.8m | $227.8m | +$20.0m |
| Net debt | $1393.7m | $1426.7m | −$33.0m |
| Net debt / EBITDA | 4.50x | 6.40x | Strengthening |
| Gross borrowings | $1.5m | $1.5m | −$0.0m |
| Payout ratio vs NPAT | 84.5% | — | — |
| Payout ratio vs FCF pre-lease | -43.9% | — | not covered |
| ROE (annualised) | 6.3% | 4.8% | Strengthening |
| HY25 share of FY25 revenue | 48.1% | — | Other half was 51.9% |
| HY25 share of FY25 EBITDA | 48.9% | — | Other half was 51.1% |
| HY25 share of FY25 NPAT | 41.6% | — | Other half was 58.4% |
| Profit from continuing operations | $95.1m | $70.3m | +$24.8m |
Source: annolyse.ai/briefings/gne-hy26
This analysis was generated using Annolyse, an AI-powered tool that extracts and analyses NZX/ASX company announcements. The underlying data is extracted from official company filings and verified against source documents. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.